220 related articles for article (PubMed ID: 37612267)
1. Single cell transcriptomic analyses implicate an immunosuppressive tumor microenvironment in pancreatic cancer liver metastasis.
Zhang S; Fang W; Zhou S; Zhu D; Chen R; Gao X; Li Z; Fu Y; Zhang Y; Yang F; Zhao J; Wu H; Wang P; Shen Y; Shen S; Xu G; Wang L; Yan C; Zou X; Chen D; Lv Y
Nat Commun; 2023 Aug; 14(1):5123. PubMed ID: 37612267
[TBL] [Abstract][Full Text] [Related]
2. Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions.
Lin W; Noel P; Borazanci EH; Lee J; Amini A; Han IW; Heo JS; Jameson GS; Fraser C; Steinbach M; Woo Y; Fong Y; Cridebring D; Von Hoff DD; Park JO; Han H
Genome Med; 2020 Sep; 12(1):80. PubMed ID: 32988401
[TBL] [Abstract][Full Text] [Related]
3. Single-cell transcriptome analysis reveals subtype-specific clonal evolution and microenvironmental changes in liver metastasis of pancreatic adenocarcinoma and their clinical implications.
Park JK; Jeong HO; Kim H; Choi JH; Lee EM; Kim S; Jang J; Choi DW; Lee SH; Kim KM; Jang KT; Lee KH; Lee KT; Lee MW; Lee JK; Lee S
Mol Cancer; 2024 May; 23(1):87. PubMed ID: 38702773
[TBL] [Abstract][Full Text] [Related]
4. Transcriptomic-Based Microenvironment Classification Reveals Precision Medicine Strategies for Pancreatic Ductal Adenocarcinoma.
George B; Kudryashova O; Kravets A; Thalji S; Malarkannan S; Kurzrock R; Chernyavskaya E; Gusakova M; Kravchenko D; Tychinin D; Savin E; Alekseeva L; Butusova A; Bagaev A; Shin N; Brown JH; Sethi I; Wang D; Taylor B; McFall T; Kamgar M; Hall WA; Erickson B; Christians KK; Evans DB; Tsai S
Gastroenterology; 2024 May; 166(5):859-871.e3. PubMed ID: 38280684
[TBL] [Abstract][Full Text] [Related]
5. Integrated genomic and transcriptomic analysis reveals unique characteristics of hepatic metastases and pro-metastatic role of complement C1q in pancreatic ductal adenocarcinoma.
Yang J; Lin P; Yang M; Liu W; Fu X; Liu D; Tao L; Huo Y; Zhang J; Hua R; Zhang Z; Li Y; Wang L; Xue J; Li H; Sun Y
Genome Biol; 2021 Jan; 22(1):4. PubMed ID: 33397441
[TBL] [Abstract][Full Text] [Related]
6. Multi-omic profiling of lung and liver tumor microenvironments of metastatic pancreatic cancer reveals site-specific immune regulatory pathways.
Ho WJ; Erbe R; Danilova L; Phyo Z; Bigelow E; Stein-O'Brien G; Thomas DL; Charmsaz S; Gross N; Woolman S; Cruz K; Munday RM; Zaidi N; Armstrong TD; Sztein MB; Yarchoan M; Thompson ED; Jaffee EM; Fertig EJ
Genome Biol; 2021 May; 22(1):154. PubMed ID: 33985562
[TBL] [Abstract][Full Text] [Related]
7. Transcriptomic landscape of endothelial cells: Key tumor microenvironment components indicating variable clinical outcomes in pancreatic ductal adenocarcinoma.
Xie P; Tan SY; Li HF; Tang HD; Zhou JH
Environ Toxicol; 2024 Feb; 39(2):572-582. PubMed ID: 37449672
[TBL] [Abstract][Full Text] [Related]
8. Single-cell mapping reveals several immune subsets associated with liver metastasis of pancreatic ductal adenocarcinoma.
Zhang Z; Zhu XQ; Yang F; Lai NN; Zhu L; Cole K; Hu BY; Li TE; Zhu Y; Zhang LM; Wang S; Zheng Y; Mao H; Zhao Y; Bruns C; Vago R; Tu B; Wong JWH; Fu DL; Qin LX; Dong QZ
Med; 2023 Oct; 4(10):728-743.e7. PubMed ID: 37633269
[TBL] [Abstract][Full Text] [Related]
9. Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU).
Hosen SMZ; Uddin MN; Xu Z; Buckley BJ; Perera C; Pang TCY; Mekapogu AR; Moni MA; Notta F; Gallinger S; Pirola R; Wilson J; Ranson M; Goldstein D; Apte M
Front Immunol; 2022; 13():1060957. PubMed ID: 36591282
[TBL] [Abstract][Full Text] [Related]
10. Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma.
Tang R; Liu X; Liang C; Hua J; Xu J; Wang W; Meng Q; Liu J; Zhang B; Yu X; Shi S
Front Immunol; 2021; 12():648917. PubMed ID: 33777046
[No Abstract] [Full Text] [Related]
11. Elucidation of Tumor-Stromal Heterogeneity and the Ligand-Receptor Interactome by Single-Cell Transcriptomics in Real-world Pancreatic Cancer Biopsies.
Lee JJ; Bernard V; Semaan A; Monberg ME; Huang J; Stephens BM; Lin D; Rajapakshe KI; Weston BR; Bhutani MS; Haymaker CL; Bernatchez C; Taniguchi CM; Maitra A; Guerrero PA
Clin Cancer Res; 2021 Nov; 27(21):5912-5921. PubMed ID: 34426439
[TBL] [Abstract][Full Text] [Related]
12. Identification of a subset of immunosuppressive P2RX1-negative neutrophils in pancreatic cancer liver metastasis.
Wang X; Hu LP; Qin WT; Yang Q; Chen DY; Li Q; Zhou KX; Huang PQ; Xu CJ; Li J; Yao LL; Wang YH; Tian GA; Yang JY; Yang MW; Liu DJ; Sun YW; Jiang SH; Zhang XL; Zhang ZG
Nat Commun; 2021 Jan; 12(1):174. PubMed ID: 33420030
[TBL] [Abstract][Full Text] [Related]
13. Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma.
Wang WQ; Liu L; Xu HX; Wu CT; Xiang JF; Xu J; Liu C; Long J; Ni QX; Yu XJ
Br J Surg; 2016 Aug; 103(9):1189-99. PubMed ID: 27256393
[TBL] [Abstract][Full Text] [Related]
14. Transcriptome profiling reveals liver metastasis-associated genes in pancreatic ductal adenocarcinoma.
Yu Y; Wang Z; Mo DH; Wang Z; Li G
Math Biosci Eng; 2021 Feb; 18(2):1708-1721. PubMed ID: 33757206
[TBL] [Abstract][Full Text] [Related]
15. Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma.
Gautam SK; Batra SK; Jain M
Mol Cancer; 2023 Jul; 22(1):118. PubMed ID: 37488598
[TBL] [Abstract][Full Text] [Related]
16. Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma.
Neuzillet C; Tijeras-Raballand A; Ragulan C; Cros J; Patil Y; Martinet M; Erkan M; Kleeff J; Wilson J; Apte M; Tosolini M; Wilson AS; Delvecchio FR; Bousquet C; Paradis V; Hammel P; Sadanandam A; Kocher HM
J Pathol; 2019 May; 248(1):51-65. PubMed ID: 30575030
[TBL] [Abstract][Full Text] [Related]
17. Thrombin-PAR1 signaling in pancreatic cancer promotes an immunosuppressive microenvironment.
Schweickert PG; Yang Y; White EE; Cresswell GM; Elzey BD; Ratliff TL; Arumugam P; Antoniak S; Mackman N; Flick MJ; Konieczny SF
J Thromb Haemost; 2021 Jan; 19(1):161-172. PubMed ID: 33064371
[TBL] [Abstract][Full Text] [Related]
18. Cancer-associated fibroblast heterogeneity is associated with organ-specific metastasis in pancreatic ductal adenocarcinoma.
Pan X; Zhou J; Xiao Q; Fujiwara K; Zhang M; Mo G; Gong W; Zheng L
J Hematol Oncol; 2021 Nov; 14(1):184. PubMed ID: 34727952
[TBL] [Abstract][Full Text] [Related]
19. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N
Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868
[TBL] [Abstract][Full Text] [Related]
20. The coagulation-related genes for prognosis and tumor microenvironment in pancreatic ductal adenocarcinoma.
Wang D; Cui SP; Chen Q; Ren ZY; Lyu SC; Zhao X; Lang R
BMC Cancer; 2023 Jun; 23(1):601. PubMed ID: 37386391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
